Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Guselkumab parent company?

See the DrugPatentWatch profile for Guselkumab

Who is the parent company of guselkumab?

Guselkumab is marketed under the brand Tremfya. The drug is made by Janssen Biotech (a unit of Johnson & Johnson), so the parent company is Johnson & Johnson. [1]

Who owns Tremfya (guselkumab) today?

Tremfya is owned and commercialized by Janssen Pharmaceuticals, which is part of Johnson & Johnson. [1]

Does guselkumab have any different manufacturers or brands by country?

Guselkumab is the international nonproprietary name for the active ingredient in Tremfya; the ownership and manufacturer relationships are tied to the Janssen/Johnson & Johnson organization. [1]

Sources

[1] https://www.janssen.com/janssen-products/tremfya



Other Questions About Guselkumab :

is guselkumab off patent in u.s. tremfya guselkumab patent expiration date tremfya guselkumab Guselkumab biosimilar? Guselkumab patent oppositions? Guselkumab patents? Guselkumab biosimilar no brasil?